{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-028349","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2022-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.090280+00:00","generated_at":"2026-06-22T07:30:35.009293+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Balchem Q3 revenue up 23.4% to $244.3M; adjusted EPS $1.00 vs $0.92 YoY","bullets":["Net sales $244.3M (+23.4% YoY); GAAP EPS $0.78, adjusted EPS $1.00.","Adjusted EBITDA $53.8M (+11.2% YoY); net earnings $25.2M (+0.9%).","Completed Bergstrom (OptiMSM) acquisition on Aug 30, 2022, adding MSM capabilities.","Cash from ops $41.6M; free cash flow $26.8M; net debt $406.1M (leverage 1.9x)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-028349","json":"https://secwatch.observer/filing/0001628280-22-028349.json","markdown":"https://secwatch.observer/filing/0001628280-22-028349.md","text":"https://secwatch.observer/filing/0001628280-22-028349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828022028349/0001628280-22-028349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828022028349/bcpc-20221104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:30:35.009293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c06be7e01fe84b7e39d5c5677e7158cce1d18f1","claim":"BALCHEM CORP reported the quarter ended September 30, 2022 results: revenue $244.3 million, net income $25.2 million, EPS $0.78.","evidence_excerpt":"in such a filing. --- EX-99.1 (EX-99.1) --- Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports Third Quarter Sales of $244.3 Million, Net Earnings of $25.2 Million, GAAP EPS of $0.78, and Adjusted EPS of $1.00 Montvale, NJ, November 4, 2022 - Balchem Corporation (NASDAQ: BCPC) reported today third quarter net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/9326/000162828022028349/0001628280-22-028349-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$244.3 million"},{"label":"Net income","value":"$25.2 million"},{"label":"EPS","value":"$0.78"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}